A sensitive reverse passive haemagglutination immunoassay for hepatic caeruloplasmin

Area of Science:

• Biochemistry
• Clinical Chemistry
• Immunology

Background:

• Caeruloplasmin is a key copper-binding protein in human serum.
• Accurate measurement of caeruloplasmin is crucial for diagnosing certain liver diseases and genetic disorders.
• Existing methods may require larger sample volumes or lack sensitivity for small tissue biopsies.

Purpose of the Study:

• To describe a novel reverse passive haemagglutination assay (RPHA) for quantifying caeruloplasmin.
• To validate the assay's sensitivity and accuracy using human liver tissue homogenates and organelle fractions.
• To compare the RPHA results with a standard method for serum caeruloplasmin measurement.

Main Methods:

• Development of a reverse passive haemagglutination assay.
• Application of the assay to human liver tissue homogenates and organelle fractions.
• Serial dilution technique for precise quantitation of caeruloplasmin.
• Validation using human serum samples and comparison with radial immunodiffusion.

Main Results:

• The RPHA accurately quantifies caeruloplasmin down to 10 ng/ml.
• The assay can detect caeruloplasmin in as little as 5 mg of wet weight human liver tissue.
• Serum caeruloplasmin values obtained by RPHA showed good correlation with the radial immunodiffusion technique.

Conclusions:

• The described RPHA is a sensitive and accurate method for measuring caeruloplasmin.
• This assay is suitable for analyzing small human liver biopsy samples.
• The RPHA offers a reliable alternative for clinical diagnostics involving caeruloplasmin quantification.